Arrowhead Pharmaceuticals Inc.

In News

Norges Bank Invests $30.41 Million in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

MarketBeat - Dec 08, 2025

Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - Yahoo Finance

Yahoo Finance - Dec 02, 2025

Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences - Business Wire

Business Wire - Dec 01, 2025

US FDA approves Arrowhead's genetic disorder drug - Reuters

Reuters - Nov 18, 2025

What dividend safety rating applies to Arrowhead Pharmaceuticals Inc. (HDP1) stock - Weekly Loss Report & Long-Term Capital Growth Strategies - Newser

Newser - Dec 04, 2025

Arrowhead Pharmaceuticals: Important Catalysts And Some Challenges Ahead (NASDAQ:ARWR) - Seeking Alpha

Seeking Alpha - Nov 17, 2025

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stock Catapults 33% Though Its Price And Business Still Lag The Industry - simplywall.st

simplywall.st - Dec 02, 2025

HC Wainwright & Co. Maintains Arrowhead Pharmaceuticals (ARWR) Buy Recommendation - Nasdaq

Nasdaq - Dec 02, 2025

Arrowhead Pharmaceuticals Poised for Growth Following Breakthrough FDA Approvals - StocksToTrade

StocksToTrade - Dec 03, 2025

RNAi biotech Arrowhead wins first FDA approval - BioPharma Dive

BioPharma Dive - Nov 18, 2025

Arrowhead Pharmaceuticals Soars with FDA Breakthrough Therapy Designation - timothysykes.com

timothysykes.com - Dec 03, 2025

Arrowhead Pharmaceuticals stock hits 52-week high at 59.19 USD - Investing.com

Investing.com - Dec 02, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment